Epidemiological Study of a Norovirus GΙΙ.17[P17] Outbreak Linked to Acute Gastroenteritis in a Cross-Border Travel Group - Shanghai Port, China, 2024 - Report - MDSpire

Epidemiological Study of a Norovirus GΙΙ.17[P17] Outbreak Linked to Acute Gastroenteritis in a Cross-Border Travel Group - Shanghai Port, China, 2024

  • By

  • Danlei Liu

  • Shiwei Yu

  • Xiangting Tian

  • Zhiyi Wang

  • Ye Lu

  • Yue Dai

  • Chunli Hu

  • Xinyi Ma

  • Mao Mao

  • Liming Xue

  • Zaijiong Yi

  • Guannan Zhang

  • Shenwei Li

  • Qiang Wang

  • Zilong Zhang

  • Zhengan Tian

  • March 4, 2026

  • 0 min

Share

Clinical Report: Epidemiological Study of a Norovirus GΙΙ.17[P17] Outbreak

Overview

This report details an outbreak of acute gastroenteritis caused by Norovirus GΙΙ.17[P17] among travelers arriving at Shanghai Port. The investigation highlights the importance of integrated genomic surveillance for real-time outbreak detection and monitoring of norovirus genotypes.

Background

Norovirus is a leading cause of acute gastroenteritis globally, with significant public health implications due to its high infectivity and rapid transmission. The rise of cross-border travel has increased the risk of norovirus outbreaks, necessitating effective surveillance and control measures. Recent genomic surveillance indicates a resurgence of the GΙΙ.17 genotype, emphasizing the need for ongoing monitoring to manage outbreaks effectively.

Data Highlights

ParameterValue
Number of travelers26
Median age44 years
Suspected cases15 (57.7%)
Close contacts11 (42.3%)
Duration of illness1-2 days (median: 2 days)

Key Findings

  • Norovirus GΙΙ.17[P17] was confirmed in 10 of the 26 travelers.
  • 57.7% of the cohort exhibited symptoms consistent with acute gastroenteritis.
  • The outbreak was linked to a 12-day tour across multiple countries.
  • No hospitalizations or fatalities were reported among the affected individuals.
  • Integrated RT-qPCR screening proved effective for real-time outbreak detection.

Clinical Implications

Healthcare professionals should be aware of the increasing prevalence of Norovirus GΙΙ.17[P17] and the potential for outbreaks among international travelers. Implementing robust surveillance and rapid diagnostic testing at points of entry can enhance outbreak management and control efforts.

Conclusion

The investigation underscores the critical role of genomic surveillance in managing norovirus outbreaks, particularly in the context of global travel. Continued monitoring and rapid response strategies are essential to mitigate the impact of norovirus infections.

References

  1. Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China - PMC
  2. Norovirus - CDC Yellow Book, 2026 edition
  3. Characteristics of Gastroenteritis Observed During a Significant Waterborne Campylobacter Outbreak in Askøy, Norway
  4. Significant Salmonella Serovar Outbreak Associated with Alfalfa Sprouts in Norway, October to December 2024
  5. Exploring Global Trends in Antimicrobial Resistance Through Sequencing of Enteric Bacteria in US Travelers Abroad
  6. Infection — Identification of intestinal pathogens in young children prior to and during episodes of acute gastroenteritis: findings from a prospective German birth cohort study (LoewenKIDS)
  7. Increase of GII.17 Norovirus Infections During the 2024–2025 Season in Multiple Cities, China - PMC
  8. Norovirus - CDC Yellow Book, 2026 edition - NCBI Bookshelf
  9. An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study - PubMed

Original Source(s)

Related Content